Article Text

PDF
Superoxide Dismutase SOD1, Encoded on Chromosome 21, but Not SOD2 Is Overexpressed in Brains of Patients With Down Syndrome
  1. Talin Gulesserian1,2,
  2. Rainer Seidl1,2,
  3. Rosmarie Hardmeier1,2,
  4. Nigel Cairns1,2,
  5. Gert Lubec1,2
  1. 1From the Department of Pediatrics, University of Vienna (T.G., R.S., R.H., G.L.), Austria
  2. 2Department of Neuropathology, Brain Bank, Institute of Psychiatry, King’s College London (N.C.), United Kingdom
  1. Address correspondence to: Gert Lubec, CChem, FRSC (UK), University of Vienna, Department of Pediatrics, Währinger Gürtel 18, A 1090 Vienna, Austria. gert.lubec{at}akh-wien.ac.at

Abstract

Background The antioxidant enzyme Cu/Zn-superoxide dismutase-1 (SOD1) gene is localized to chromosome 21q22.1 and catalyzes the dismutation of superoxide anions to hydrogen peroxide, which may lead to the increased production of active oxygen species in Down Syndrome (DS), trisomy 21. Although a number of studies have addressed this question, proposing the overexpression hypothesis, no specific protein-chemical data on SOD protein levels in the brains of patients with DS are available.

Methods We therefore determined the protein SOD-1 and SOD-2 levels in the brains of controls (n=9) and adult patients with DS (n=9) and Alzheimer disease (AD; n=9). Two-dimensional electrophoresis followed by matrix-assisted laser desorption/ionization-mass spectroscopy detection and identification was used for the analyses.

Results We found significantly increased SOD-1 levels in DS temporal, parietal, and occipital cortex, whereas SOD-1 was decreased in the AD temporal cortex and SOD-2 was comparable between all groups.

Conclusions Increased SOD-1 levels in patients with DS may reflect the overexpression by the trisomic state, as a response to the oxidative stress, as has been proposed in DS by several authors. However, it well may be that glial proliferation, which is markedly increased in DS brain, may underlie the increased brain levels of this ubiquitous protein. The decrease of SOD1 in the temporal cortex of patients with AD may reflect an antiapoptotic mechanism or simply cell loss in the brain.

Key Words:
  • SOD1
  • SOD2
  • two dimensional electrophoresis
  • MALDI-MS
  • brain
  • Down Syndrome
  • Alzheimer disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.